EXAS
Exact Sciences Corp
Price:  
57.53 
USD
Volume:  
2,950,981.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

EXAS Relative Valuation

-182.4%
Upside

As of 2024-02-26, the Relative Valuation of Exact Sciences Corp (EXAS) is (47.38) USD. This relative valuation is based on P/E multiples. With the latest stock price at 57.53 USD, the upside of Exact Sciences Corp based on Relative Valuation is -182.4%.

The range of the Relative Valuation is (48.98) - (47.11) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 31.4x - 35.1x 33.2x
Forward P/E multiples 24.8x - 30.2x 27.5x
Fair Price (48.98) - (47.11) (47.38)
Upside -185.1% - -181.9% -182.4%
57.53 USD
Stock Price
(47.38) USD
Fair Price

EXAS Relative Valuation - Historical P/E Data

Date P/E
2024-02-26 -37.41
2024-02-23 -36.88
2024-02-22 -38.14
2024-02-21 -40.57
2024-02-20 -40.22
2024-02-16 -39.09
2024-02-15 -39.16
2024-02-14 -39.80
2024-02-13 -38.11
2024-02-12 -39.80
2024-02-09 -38.88
2024-02-08 -39.09
2024-02-07 -39.20
2024-02-06 -41.41
2024-02-05 -40.03
2024-02-02 -41.06
2024-02-01 -40.98
2024-01-31 -41.93
2024-01-30 -42.11
2024-01-29 -42.86
2024-01-26 -41.21
2024-01-25 -41.20
2024-01-24 -41.17
2024-01-23 -42.09
2024-01-22 -42.32
2024-01-19 -42.22
2024-01-18 -41.80
2024-01-17 -41.07
2024-01-16 -42.32
2024-01-12 -43.03
2024-01-11 -44.00
2024-01-10 -44.95
2024-01-09 -44.61
2024-01-08 -45.24
2024-01-05 -46.93
2024-01-04 -45.66
2024-01-03 -44.84
2024-01-02 -47.29
2023-12-29 -47.43
2023-12-28 -48.54
2023-12-27 -48.52
2023-12-26 -48.50
2023-12-22 -47.13
2023-12-21 -45.79
2023-12-20 -43.15
2023-12-19 -44.51
2023-12-18 -41.41
2023-12-15 -42.25
2023-12-14 -43.47
2023-12-13 -43.41